Small DNA tumor viruses: Large contributors to biomedical sciences

Virology

Volumn 384, Issue 2, 2009, Pages 256-259

  Howley, Peter M ^a   Livingston, David M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

BPV; HPV; p53; Papillomavirus; Polyoma; SV40

Indexed keywords

ADENOVIRUS; CARCINOGENESIS; DNA REPLICATION; DNA TRANSCRIPTION; DNA TUMOR VIRUS; GENOME; HERPES VIRUS; HUMAN; MAMMAL CELL; MEDICAL RESEARCH; NEOPLASM; NONHUMAN; PAPILLOMA VIRUS; PAPOVAVIRUS; POLYOMA VIRUS; PRIORITY JOURNAL; SHORT SURVEY;

ADENOVIRIDAE; CELL TRANSFORMATION, VIRAL; DNA REPLICATION; DNA TUMOR VIRUSES; HUMANS; NEOPLASMS; PAPILLOMAVIRIDAE; POLYOMAVIRUS;

BOVINE PARVOVIRUS; HUMAN PAPILLOMAVIRUS; MAMMALIA; PAPILLOMAVIRIDAE; POLYOMAVIRUS;

EID: 59349088766     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.12.006     Document Type: Short Survey

References (51)

1. Banerji J., Rusconi S., and Schaffner W. Expression of a beta-globin gene is enhanced by remote SV40 DNA sequences. Cell 27 (1981) 299-308
2. Benoist C., and Chambon P. In vivo sequence requirements of the SV40 early promotor region. Nature 290 (1981) 304-310
3. Berget S.M., Moore C., and Sharp P.A. Spliced segments at the 5′ terminus of adenovirus 2 late mRNA. Proc. Natl. Acad. Sci. U.S.A. 74 (1977) 3171-3175
4. Boshart M., Gissman L., Ikenberg H., Kleinheinz A., Scheurlen W., and zur Hausen H. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3 (1984) 1151-1157
5. Challberg M.D., and Kelly Jr. T.J. Adenovirus DNA replication in vitro. Proc. Natl. Acad. Sci. U.S.A. 76 (1979) 655-659
6. Chow L.T., Gelinas R.E., Broker T.R., and Roberts R.J. An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 12 (1977) 1-8
7. Courtneidge S.A., and Smith A.E. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303 (1983) 435-439
8. Danna K.J., Sack Jr. G.H., and Nathans D. Studies of simian virus 40 DNA. VII. A cleavage map of the SV40 genome. J. Mol. Biol. 78 (1973) 363-376
9. DeCaprio J.A., Ludlow J.W., Figge J., Shew J.Y., Huang C.M., Lee W.H., Marsillo E., Paucha E., and Livingston D.M. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 54 (1988) 275-283
10. Durst M., Gissmann L., Idenburg H., and zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 3812-3815
11. Dynan W.S., and Tjian R. The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter. Cell 35 (1983) 79-87
12. Dyson N. The regulation of E2F by pRB-family proteins. Genes Dev. 12 (1998) 2245-2262
13. Dyson N., Howley P.M., Munger K., and Harlow E. The human papillomavirus-16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 243 (1989) 934-937
14. Ellermann V., and Bang O. Experimentelle leukamie bei huhnern. Zentralbl. Bakteriol. 46 (1908) 595-609
15. Feng H., Shuda M., Chang Y., and Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319 (2008) 1096-1100
16. Fiers W., Contreras R., Haegemann G., Rogiers R., Van de Voorde A., Van Heuverswyn H., Van Herreweghe J., Volckaert G., and Ysebaert M. Complete nucleotide sequence of SV40 DNA. Nature 273 (1978) 113-120
17. Fitzgerald M., and Shenk T. The sequence 5′-AAUAAA-3′ forms parts of the recognition site for polyadenylation of late SV40 mRNAs. Cell 24 (1981) 251-260
18. Fried M. Cell-transforming ability of a temperature-sensitive mutant of polyoma virus. Proc. Natl. Acad. Sci. U.S.A. 53 (1965) 486-491
19. Gross L. Pathogenic properties, and "vertical" transmission of the mouse leukemia agent. Proc. Soc. Exp. Biol. Med. 62 (1951) 523-548
20. Gross L. A filtrable agent, recovered from Akr leukemia extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 83 (1953) 414-421
21. Hamer D.H., and Leder P. Expression of the chromosomal mouse Beta maj-globin gene cloned in SV40. Nature 281 (1979) 35-40
22. Kalderon D., Roberts B.L., Richardson W.D., and Smith A.E. A short amino acid sequence able to specify nuclear location. Cell 39 (1984) 499-509
23. Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Barr E., Alvarez F.B., Chiacchierini L.M., and Jansen K.U. A controlled trial of a human papillomavirus type 16 vaccine. N. Engl. J. Med. 347 (2002) 1645-1651
24. Kovesdi I., Reichel R., and Nevins J.R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45 (1986) 219-228
25. Land H., Parada L.F., and Weinberg R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304 (1983) 596-602
26. Lane D.P., and Crawford L.V. T antigen is bound to a host protein in SV40-transformed cells. Nature 278 (1979) 261-263
27. Lanford R.E., and Butel J.S. Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell 37 (1984) 801-813
28. Li J.J., and Kelly T.J. Simian virus 40 DNA replication in vitro. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 6973-6977
29. Linzer D., and Levine A.J. Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell 17 (1979) 43-52
30. Mulligan R.C., Howard B.H., and Berg P. Synthesis of rabbit beta-globin in cultured monkey kidney cells following infection with a SV40 beta-globin recombinant genome. Nature 277 (1979) 108-114
31. Orth G., Jablonska S., Favre M., Croissant O., Jarzabek-Chorzelska M., and Rzesa G. Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis. Proc. Nat. Acad. Sci. USA. 75 (1978) 1537-1541
32. Pallas D.C., Shahrik L.K., Martin B.L., Jaspers S., Miller T.B., Brautigan D.L., and Roberts T.M. Polyoma small and middle T antigens and SV40 small T antigen form stable complexes with protein phosphatase 2A. Cell 60 (1990) 167-176
33. Poulin D.L., and DeCaprio J.A. Is there a role for SV40 in human cancer?. J. Clin. Oncol. 24 (2006) 4356-4365
34. Querido E., Marcellus R.C., Lai A., Charbonneau R., Teodoro J.G., Ketner G., and Branton P.E. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71 (1997) 3788-3798
35. Reddy V.B., Thimmappaya B., Dhar R., Subramanian K.N., Zain B.S., Pan J., Ghosh P.K., Celma M.L., and Weissman S.M. The genome of simian virus 40. Science 200 (1978) 494-502
36. Rous P. A sarcoma of the fowl transmissible by an agent separable from the tumor cells. J. Exp. Med. 13 (1911) 397-411
37. Rous P., and Beard J.W. Carcinomatous changes in virus-induced papillomas of rabbits. Proc. Soc. Exp. Biol. Med. 32 (1935) 578-580
38. Salunke D.M., Caspar D.L., and Garcea R.L. Polymorphism in the assembly of polyomavirus capsid protein VP1. Biophys. J. 56 (1989) 887-900
39. Sarnow P., Ho Y.S., Williams J., and Levine A.J. Adenovirus E1b-58 kD tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kD cellular protein in transformed cells. Cell 28 (1982) 387-394
40. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., and Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63 (1990) 1129-1136
41. Scheffner M., Huibregtse J.M., Vierstra R.D., and Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquination of p53. Cell 75 (1993) 495-505
42. Schrier P.I., Bernards R., Vaessen R.T., Houweling A., and van der Eb A.J. Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 305 (1983) 771-775
43. Shah K.V. SV40 and human cancer: a review of recent data. Int. J. Cancer 120 (2007) 215-223
44. Shope R.E., and Hurst E.W. Infectious papillomatosis of rabbits; with a note on the histopathology. J. Exp. Med. 58 (1933) 607-624
45. Stewart S.E. Leukemia in mice produced by a filterable agent present in AKR leukemic tissues with notes on a sarcoma produced by the same agent. Anat. Rev. 117 (1953) 532
46. Sweet B.H., and Hilleman M.R. The vacuolating virus, S.V. 40. Proc. Soc. Exp. Biol. Med. 105 (1960) 420-427
47. Van den Elsen P., Houweling A., and Van der Eb A. Expression of region E1b of human adenoviruses in the absence of region E1a is not sufficient for complete transformation. Virology 128 (1983) 377-390
48. Walter G., Ruediger R., Slaughter C., and Mumby M. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 2521-2525
49. Werness B.A., Levine A.J., and Howley P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248 (1990) 76-79
50. Whyte P., Buchkovich K.J., Horowitz J.M., Friend S.H., Raybuck M., Weinberg R.A., and Harlow E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334 (1988) 124-129
51. Yang L., Li R., Mohr I.J., Clark R., and Botchan M.R. Activation of BPV-1 replication in vitro by the transcription factor E2. Nature 353 (1991) 628-632